PERTH, Australia – Melbourne-based Starpharma Holdings Ltd. has entered a sales and marketing deal with Mundipharma International Ltd., which gives Mundipharma sales and marketing rights to Vivagel BV for bacterial vaginosis (BV) in Asia, the Middle East, Africa and the majority of Latin America.